Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Availability of genome-matched therapy based on clinical practice.
Hayashi N, Mori S, Ohmoto A, Fukada I, Yamazaki M, Hosonaga M, Wang X, Ueki A, Kiyotani K, Tonooka A, Takeuchi K, Takahashi S. Hayashi N, et al. Among authors: takahashi s. Int J Clin Oncol. 2024 Apr 26. doi: 10.1007/s10147-024-02533-z. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38668785
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.
Nakano K, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Ono M, Taira S, Nishizawa M, Wang X, Ohmoto A, Sato Y, Fukuda N, Urasaki T, Takahashi S. Nakano K, et al. Among authors: takahashi s. Mol Clin Oncol. 2021 Jan;14(1):13. doi: 10.3892/mco.2020.2175. Epub 2020 Nov 25. Mol Clin Oncol. 2021. PMID: 33282288 Free PMC article.
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin.
Nakano K, Fukuda N, Sato Y, Urasaki T, Ohmoto A, Wang X, Hayashi N, Suto H, Udagawa S, Oki R, Yunokawa M, Ono M, Tomomatsu J, Minami Y, Hayakawa K, Tanizawa T, Ae K, Matsumoto S, Takahashi S. Nakano K, et al. Among authors: takahashi s. Oncology. 2022;100(4):238-246. doi: 10.1159/000522303. Epub 2022 Jan 31. Oncology. 2022. PMID: 35100601
Assessment of a cancer genomic profile test for patients with metastatic breast cancer.
Fukada I, Mori S, Hayashi N, Hosonaga M, Yamazaki M, Wang X, Kawai S, Inagaki L, Ozaki Y, Kobayashi K, Hara F, Kobayashi T, Ueki A, Osako T, Tonooka A, Takeuchi K, Ueno T, Takano T, Ohno S, Takahashi S. Fukada I, et al. Among authors: takahashi s. Sci Rep. 2022 Mar 21;12(1):4813. doi: 10.1038/s41598-022-08925-3. Sci Rep. 2022. PMID: 35315838 Free PMC article.
Druggable gene alterations in Japanese patients with rare malignancy.
Ohmoto A, Hayashi N, Fukada I, Yamazaki M, Yunokawa M, Kasuga A, Shinozaki E, Ueki A, Tonooka A, Takeuchi K, Mori S, Kiyotani K, Takahashi S. Ohmoto A, et al. Among authors: takahashi s. Neoplasia. 2022 Nov;33:100834. doi: 10.1016/j.neo.2022.100834. Epub 2022 Sep 8. Neoplasia. 2022. PMID: 36088851 Free PMC article.
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
Ohmoto A, Sato Y, Asaka R, Fukuda N, Wang X, Urasaki T, Hayashi N, Sato Y, Nakano K, Yunokawa M, Ono M, Tomomatsu J, Toshiyasu T, Mitani H, Takeuchi K, Mori S, Takahashi S. Ohmoto A, et al. Among authors: takahashi s. Mod Pathol. 2021 Nov;34(11):1979-1989. doi: 10.1038/s41379-021-00869-9. Epub 2021 Jul 10. Mod Pathol. 2021. PMID: 34247193 Free PMC article.
11,143 results
You have reached the last available page of results. Please see the User Guide for more information.